Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2672145 | 0.94 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL940005 | 0.94 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL35668 | 0.85 | ADRB2 (0.45) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL18528566 | 0.82 | — | — | |
| SCHEMBL6448719 | 0.82 | ADRB2 (0.43) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL1538446 | 0.82 | ADRB2 (0.43) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL31482751 | 0.82 | ADRB2 (0.43) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL11707211 | 0.82 | ADRB2 (0.31) | ADRB2ADRB1ADRB3 | |
| SCHEMBL9147120 | 0.80 | ADRB2 (0.41) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL9147450 | 0.80 | ADRB2 (0.41) | ADRB2ADRB1ADRB3TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570771-B2 | Curing catalyst used for curing of polymer, production method for said curing catalyst, mositure-curable composition, and production method for cured product | NITTO KASEI CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| EP-4174052-B1 | CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOISTURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED PRODUCT | NITTO KASEI CO LTD (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-20240132641-A1 | ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND PREPARATION METHOD THEREFOR | SINOPEC YANGZI PETROCHEMICAL LTD. (BV) | 2024-04-25 | — | — | US | disclosed |
| EP-4286420-A1 | ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND PREPARATION METHOD THEREFOR | China Petroleum & Chemical Corporation (CN) | 2023-12-06 | — | — | EP | disclosed |
| US-20230257487-A1 | CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOSITURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| EP-4174052-A1 | CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOISTURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED PRODUCT | Nitto Kasei Co., Ltd. (JP) | 2023-05-03 | — | — | EP | disclosed |
| EP-2495261-B1 | SUPPORTED NON-METALLOCENE CATALYST, MANUFACTURING METHOD AND APPLICATION THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2020-08-26 | — | — | EP | disclosed |
| EP-2500365-B1 | SUPPORTED NON-METALLOCENE CATALYST AND PREPARATION METHOD AND USES THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2020-05-06 | — | — | EP | disclosed |
| EP-2500364-B1 | SUPPORTED NON-METALLOCENE CATALYST PREPARATION METHOD AND APPLICATION THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2020-03-04 | — | — | EP | disclosed |
| EP-2202246-B1 | NON-METALLOCENE CATALYST SUPPORTED ON MAGNESIUM COMPOUND AND ITS PREPARATION METHOD | SINOPEC YANGZI PETROCHEMICAL (CN) | 2016-06-15 | — | — | EP | disclosed |
| US-20120226005-A1 | SUPPORTED NONMETALLOCENE CATALYST, PREPARATION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2012-09-06 | — | — | US | disclosed |
| EP-2495261-A1 | SUPPORTED NON-METALLOCENE CATALYST, MANUFACTURING METHOD AND APPLICATION THEREOF | China Petroleum & Chemical Corporation (CN) | 2012-09-05 | — | — | EP | disclosed |
| EP-2495263-A1 | SUPPORTED NON-METALLOCENE CATALYST, PREPARATION METHOD AND USES THEREOF | China Petroleum & Chemical Corporation (CN) | 2012-09-05 | — | — | EP | disclosed |
| US-20120214955-A1 | SUPPORTED NONMETALLOCENE CATALYST, PREPARATION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2012-08-23 | — | — | US | disclosed |
| US-20120214957-A1 | SUPPORTED NONMETALLOCENE CATALYST, PREPARATION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2012-08-23 | — | — | US | disclosed |
| US-8193288-B2 | Supported nonmetallocene catalyst and preparation thereof | Sinopec Yangzi Petro-Chemical Ltd. (CN) | 2012-06-05 | — | — | US | disclosed |
| US-20110237764-A1 | MAGNESIUM COMPOUND-SUPPORTED NONMETALLOCENE CATALYST AND PREPARATION THEREOF | SINOPEC YANGZI PETROCHEMICAL COMPANY LTD. (CN) | 2011-09-29 | — | — | US | disclosed |
| US-20110152486-A1 | SUPPORTED NONMETALLOCENE CATALYST AND PREPARATION THEREOF | SINOPEC YANGZI PETRO-CHEMICAL COMPANY LTD. (CN) | 2011-06-23 | — | — | US | disclosed |
| EP-2202246-A1 | NON-METALLOCENE CATALYST SUPPORTED ON MAGNESIUM COMPOUND AND ITS PREPARATION METHOD | Sinopec Yangzi Petrochemical Company Ltd. (CN) | 2010-06-30 | — | — | EP | disclosed |
| EP-2202247-A1 | SUPPORTED NON-METALLOCENE CATALYST AND ITS PREPARATION METHOD | Sinopec Yangzi Petrochemical Company Ltd. (CN) | 2010-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570771-B2 | Curing catalyst used for curing of polymer, production method for said curing catalyst, mositure-curable composition, and production method for cured product | RPS6KB1, RPS6KA1, RPS6KB2 | ADRB2 1818/4885ADRB1 1801/4885ADRB3 2794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.